Longevity Venture Advisors

Longevity Venture Advisors is a specialized investment and strategic advisory firm dedicated to the longevity and life sciences industry. The firm primarily operates as the management and advisory arm for the Longevity Vision Fund, a venture capital vehicle that invests in breakthrough technologies aimed at extending the healthy human lifespan. Their investment focus spans several key areas, including regenerative medicine, artificial intelligence in healthcare, organ regeneration, and molecular diagnostics. By providing capital and strategic guidance, Longevity Venture Advisors helps early-stage startups navigate the path from scientific discovery to commercial viability. The firm is led by Sergey Young and maintains a strong presence in the global longevity ecosystem, fostering innovation that seeks to make life-extension technologies accessible to a broader population.